Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Why do so many seniors with memory loss and dementia never get tested?

  • 'Off switch' for pain discovered: Activating the adenosine A3 receptor subtype is key to powerful pain relief

  • Full-day preschool linked with increased school readiness compared with part-day

  • Diagnosing deafness early will help teenagers' reading development

  • Why do people with autism see faces differently?

  • Sportswomen still second best to sportsmen, in the press

  • Inpatient psychotherapy is effective in Germany

  • How various brain areas interact in decisions

  • Pleasure at another's misfortune is evident in children as young as two

  • Isolation of important centres in brain results in age-related memory deficits

  •